Title: Methods and Compositions for Modulating Tissue Factor.
Number: : 20050096289.
Filed: Aug. 5, 2004.
Inventor: Hans Prydz, University of Oslo.
The invention, the patent application's abstract states, "features nucleic acid molecules, specifically short interfering RNA molecules, that are able to modulate the expression of TF and methods for using such molecules for the treatment of coagulative disorders and for the prevention and treatment of cancer."